Yesterday we wrote about the European Commission's ambitious plans to make the results of publicly-funded research freely available as open access ; now comes news of a major opening up in the world of pharmaceutical data : Europe's medicines regulator, criticised in the past for excessive secrecy,...
FULL ARTICLE AT Tech Dirt